BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33585640)

  • 1. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature.
    Zhang Y; Wu D; Zhao B; Tian XL; Yao TC; Li F; Liu WF; Shi AP
    World J Clin Cases; 2021 Feb; 9(4):919-926. PubMed ID: 33585640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.
    Aleman Espino A; Bernal IC; Guarecuco JE; El-Tawil R; Masri MM
    Cureus; 2023 May; 15(5):e39583. PubMed ID: 37384084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports.
    Yang H; Li L; Zhang M; Zhang S; Xu S; Ma X
    Medicine (Baltimore); 2017 Oct; 96(40):e8200. PubMed ID: 28984771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review.
    Xu R; Li J; Zhang Y; Jing H; Zhu Y
    Medicine (Baltimore); 2017 Dec; 96(51):e9312. PubMed ID: 29390502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node metastasis as the first manifestation of male occult breast cancer: A Case Report.
    Wang X; Fan L; Yan W; Zhang Q; Bao S; Wang Y; Bao X; Liu L
    Medicine (Baltimore); 2018 Dec; 97(50):e13706. PubMed ID: 30558087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case Report of Male Occult Breast Cancer First Manifesting as Axillary Lymph Node Metastasis With Part of Metastatic Mucinous Carcinoma.
    He M; Liu H; Jiang Y
    Medicine (Baltimore); 2015 Jun; 94(25):e1038. PubMed ID: 26107674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
    Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
    Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult Invasive Lobular Carcinoma Presenting as an Axillary Skin Metastatic Lesion Underwent Neoadjuvant Endocrine Therapy and Surgical Resection: A Case Report and Review of Literature.
    Busbait S; Alkhalifa AM; Aljohani S; Alhaddad H
    Breast Cancer (Dove Med Press); 2022; 14():145-152. PubMed ID: 35669610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult breast cancer presenting as axillary lymphadenopathy - Case Report.
    Camarneiro R; Ferreira Á; Barros M; Brito E Melo M
    Int J Surg Case Rep; 2022 Oct; 99():107677. PubMed ID: 36162357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
    Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
    Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features, psychological status, and prognosis of 33 patients with occult breast cancer.
    Wang HM; Yu AY; Li LL; Ma LY; Cao MH; Yang YL; Qin XB; Tang JJ; Han ZX
    World J Psychiatry; 2024 Jan; 14(1):76-87. PubMed ID: 38327892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Four Cases of Occult Breast Cancer Treated with Breast Conserving Therapy after Neoadjuvant Chemotherapy].
    Miyoshi T; Shiobara M; Wakatsuki K; Arai S; Suda K; Miyazawa K; Aida T; Takahashi Y; Yoshioka S
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1149-1151. PubMed ID: 29394563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Neoadjuvant Versus Adjuvant Chemotherapy on the Extent of Axillary Surgery for Clinically Node-Negative Breast Cancers of Triple-Negative and HER2-Overexpressing Phenotypes.
    Thompson JL; Wrubel E; Davis AT; Koehler T; Chung MH; Wright GP
    Clin Breast Cancer; 2020 Oct; 20(5):390-394. PubMed ID: 32444317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
    Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
    Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.